Rigel Pharmaceuticals, Inc. (RIGL): Price and Financial Metrics

RIGL POWR Grades

• Quality is the dimension where RIGL ranks best; there it ranks ahead of 91.6% of US stocks.
• The strongest trend for RIGL is in Stability, which has been heading down over the past 179 days.
• RIGL's current lowest rank is in the Stability metric (where it is better than 5.88% of US stocks).

RIGL Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for RIGL is 4.91 -- better than 91.87% of US stocks.
• Price to trailing twelve month operating cash flow for RIGL is currently 91.42, higher than 94.93% of US stocks with positive operating cash flow.
• With a year-over-year growth in debt of -21.8%, Rigel Pharmaceuticals Inc's debt growth rate surpasses only 18.43% of about US stocks.
• Stocks that are quantitatively similar to RIGL, based on their financial statements, market capitalization, and price volatility, are SEAC, TCON, ALLT, GEOS, and ARAY.
• Visit RIGL's SEC page to see the company's official filings. To visit the company's web site, go to www.rigel.com.

RIGL Valuation Summary

• In comparison to the median Healthcare stock, RIGL's price/sales ratio is 60.35% lower, now standing at 4.5.
• RIGL's price/sales ratio has moved down 11.1 over the prior 243 months.
• RIGL's EV/EBIT ratio has moved down 148 over the prior 243 months.

Below are key valuation metrics over time for RIGL.

RIGL Growth Metrics

Its 2 year net income to common stockholders growth rate is now at 67.78%.
• The 2 year revenue growth rate now stands at 11280.56%.
• Its 4 year net income to common stockholders growth rate is now at 44.71%.

Over the past 70 months, RIGL's revenue has gone up $117,490,000.

The table below shows RIGL's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	149.236	5.878	-17.914
2021-09-30	147.277	9.392	-14.51
2021-06-30	144.123	0.207	-7.732
2021-03-31	133.878	-69.047	-11.487
2020-12-31	108.621	-52.185	-29.744
2020-09-30	105.571	-46.262	-27.707

RIGL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• RIGL has a Quality Grade of B, ranking ahead of 89.87% of graded US stocks.
• RIGL's asset turnover comes in at 0.825 -- ranking 30th of 682 Pharmaceutical Products stocks.
• GERN, NEOG, and VNDA are the stocks whose asset turnover ratios are most correlated with RIGL.

The table below shows RIGL's key quality metrics over time.